CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapySol Aldrete, Vincent C. Marconi, Jeong Hoon Jang et al.|PLoS ONE|2020Cited by 18
958P Phase I/II study of 7MW3711, a novel B7-H3-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumorsXinmei Liang, Penghao Wang, Lili Yang et al.|Annals of Oncology|2025Cited by 0